Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

CaRE2 Cancer Research Link©: Social Determinants of Health on Cancer Outcomes in Black Populations

Kenneth Stokes, Lynette Jones and Dr Herman Tucker
CaRE2 Cancer Research Link©: Social Determinants of Health on Cancer Outcomes in Black Populations ( Kenneth Stokes, Lynette Jones and Dr Herman Tucker )
4 Nov 2020

VHL/HIF and VEGF inhibitors in clear cell renal cell carcinoma

Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA
VHL/HIF and VEGF inhibitors in clear cell renal cell carcinoma ( Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA )
4 Nov 2020

Prospective validation of single mouse testing by the paediatric preclinical testing consortium

Dr Peter Houghton - Greehey Children's Cancer Institute, San Antonio, USA
Prospective validation of single mouse testing by the paediatric preclinical testing consortium ( Dr Peter Houghton - Greehey Children's Cancer Institute, San Antonio, USA )
4 Nov 2020

The ENA virtual meeting 2020

Dr. Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA
The ENA virtual meeting 2020 ( Dr. Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA )
4 Nov 2020

Bevacizumab-induced hypertension and proteinuria: A genome-wide analysis of more than 1,000 patients

Prof Federico Innocenti - University of North Carolina, Chapel Hill, USA
Bevacizumab-induced hypertension and proteinuria: A genome-wide analysis of more than 1,000 patients ( Prof Federico Innocenti - University of North Carolina, Chapel Hill, USA )
4 Nov 2020

Adagrasib in advanced/metastatic NSCLC with KRAS G12C mutation

Dr Pasi Janne - Dana Farber Cancer Institute, Boston, USA
Adagrasib in advanced/metastatic NSCLC with KRAS G12C mutation ( Dr Pasi Janne - Dana Farber Cancer Institute, Boston, USA )
4 Nov 2020

Development of novel inhibitors of KRASG12C

Dr Kevan Shokat - University of California San Francisco, San Francisco, USA
Development of novel inhibitors of KRASG12C ( Dr Kevan Shokat - University of California San Francisco, San Francisco, USA )
4 Nov 2020

Impact of angiotensin II pathway inhibition on tumour response to anti PD(L)1 based therapy

Dr Julius Strauss - National Institutes of Health, Bethseda, USA
Impact of angiotensin II pathway inhibition on tumour response to anti PD(L)1 based therapy ( Dr Julius Strauss - National Institutes of Health, Bethseda, USA )
4 Nov 2020

Managing multiple myeloma during the COVID-19 pandemic in Brazil

Dr Vania Hungria - Santa Casa de São Paulo, São Paulo, Brazil
Managing multiple myeloma during the COVID-19 pandemic in Brazil ( Dr Vania Hungria - Santa Casa de São Paulo, São Paulo, Brazil )
3 Nov 2020

Updates in surgical oncology from SIOG 2020

Dr Isacco Montroni - Ospedale per gli Infermi, Faenza, Italy
Updates in surgical oncology from SIOG 2020 ( Dr Isacco Montroni - Ospedale per gli Infermi, Faenza, Italy )
2 Nov 2020

Inter-laboratory concordance in clinical trials

Prof Ian Cree - International Agency for Research on Cancer
Inter-laboratory concordance in clinical trials ( Prof Ian Cree - International Agency for Research on Cancer )
2 Nov 2020

Critical issues in drug and biomarker development

Prof Tracy Lively - National Cancer Institute, USA
Critical issues in drug and biomarker development ( Prof Tracy Lively - National Cancer Institute, USA )
2 Nov 2020